SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001469709-15-000152
Filing Date
2015-04-03
Accepted
2015-04-03 17:02:06
Documents
4
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ENDV 10-K 12/31/14 endo10k_123114apg.htm 10-K 421539
2 GRAPHIC endo10k_123114apg001.jpg GRAPHIC 63923
3 EXHIBIT 31.1 ex31_1apg.htm EX-31.1 10370
4 EXHIBIT 32.1 ex32_1apg.htm EX-32.1 3693
  Complete submission text file 0001469709-15-000152.txt   525101
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-176954 | Film No.: 15751815
SIC: 2834 Pharmaceutical Preparations